Information Library
Results for: Case Studies - Business transformation
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Securing Compliance
January 27, 2011
Our customer trusted Quintiles to handle the entire project, and – equally important – to ensure timely delivery. -
Transforming R&D
May 18, 2010
Faced with significant pipeline productivity challenges and an overly complex quality system, Quintiles paved the way for innovation. -
Managing Alliances with the Balanced Scorecard
January 11, 2010
“Managing Alliances with the Balanced Scorecard” details how Solvay Pharmaceuticals and Quintiles managed their innovative development alliance to deliver value for both companies. -
Enabling Transformation
September 30, 2009
Biovitrum found an ideal opportunity to transform itself into a fully integrated specialty pharmaceutical company from a biotech discovery and early clinical development company. -
Making the Most of a Smart Move
March 26, 2009
In late 2007, Scotland-based ProStrakan Group plc seemed to have everything going for it: four new European product introductions planned for an 18-month period and near-term product launches with an aggregate peak sales potential of $400 to $500 million, both backed by a 340-person pan-European salesforce. -
Grabbing a Leadership Position
March 26, 2009
Astellas-Quintiles Alliance Establishes Market Leadership Platform for Vesicare -
Gain Capital & Retain Value
March 24, 2009
Cell Therapeutics was in need of capital to fund ongoing development expenses, but was not interested in further equity dilution. As an alternative, they considered monetizing a royalty interest in Trisenox®, their only marketed oncology product.
Page 1 of 1 (7 results)
